Todd Hankinson
Concepts (446)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Craniopharyngioma | 21 | 2025 | 82 | 7.480 |
Why?
| Pituitary Neoplasms | 18 | 2025 | 183 | 5.620 |
Why?
| Arnold-Chiari Malformation | 13 | 2025 | 31 | 3.560 |
Why?
| Neurosurgical Procedures | 14 | 2024 | 170 | 3.480 |
Why?
| Brain Neoplasms | 27 | 2025 | 1163 | 3.450 |
Why?
| Hydrocephalus | 16 | 2025 | 108 | 3.430 |
Why?
| Brain Stem Neoplasms | 5 | 2016 | 89 | 1.850 |
Why?
| Atlanto-Axial Joint | 7 | 2020 | 13 | 1.670 |
Why?
| Magnetic Resonance Imaging | 21 | 2023 | 3371 | 1.650 |
Why?
| Joint Instability | 7 | 2020 | 166 | 1.620 |
Why?
| Child | 87 | 2025 | 20636 | 1.600 |
Why?
| Ganglioglioma | 4 | 2016 | 31 | 1.570 |
Why?
| Decompression, Surgical | 9 | 2024 | 99 | 1.530 |
Why?
| Spinal Injuries | 4 | 2022 | 52 | 1.460 |
Why?
| Ependymoma | 10 | 2024 | 176 | 1.420 |
Why?
| Spinal Fusion | 9 | 2024 | 230 | 1.370 |
Why?
| Ventriculoperitoneal Shunt | 9 | 2024 | 37 | 1.340 |
Why?
| Glioma | 5 | 2021 | 353 | 1.290 |
Why?
| Infratentorial Neoplasms | 7 | 2024 | 60 | 1.210 |
Why?
| Cerebrospinal Fluid Shunts | 9 | 2025 | 32 | 1.200 |
Why?
| Pons | 4 | 2016 | 30 | 1.190 |
Why?
| Child, Preschool | 43 | 2025 | 10378 | 1.170 |
Why?
| Occipital Bone | 5 | 2024 | 18 | 1.160 |
Why?
| Cervical Atlas | 3 | 2024 | 4 | 1.130 |
Why?
| Sella Turcica | 2 | 2017 | 16 | 1.120 |
Why?
| Xanthomatosis | 2 | 2017 | 11 | 1.110 |
Why?
| Cervical Vertebrae | 9 | 2025 | 132 | 1.080 |
Why?
| Dura Mater | 3 | 2021 | 31 | 1.070 |
Why?
| Tomography, X-Ray Computed | 11 | 2022 | 2509 | 1.020 |
Why?
| Syringomyelia | 5 | 2024 | 12 | 1.010 |
Why?
| Humans | 128 | 2025 | 128019 | 0.940 |
Why?
| Machine Learning | 4 | 2025 | 442 | 0.870 |
Why?
| Hematoma, Epidural, Spinal | 1 | 2023 | 3 | 0.860 |
Why?
| Infant | 32 | 2025 | 8912 | 0.850 |
Why?
| Cellular Senescence | 1 | 2024 | 173 | 0.800 |
Why?
| Ventriculostomy | 7 | 2024 | 22 | 0.800 |
Why?
| Neck Injuries | 1 | 2022 | 20 | 0.800 |
Why?
| Neural Tube Defects | 4 | 2019 | 63 | 0.780 |
Why?
| Image Processing, Computer-Assisted | 2 | 2020 | 734 | 0.780 |
Why?
| Adolescent | 44 | 2025 | 20158 | 0.760 |
Why?
| Neurosurgery | 3 | 2013 | 37 | 0.750 |
Why?
| SEER Program | 4 | 2018 | 206 | 0.740 |
Why?
| Infant, Newborn | 16 | 2025 | 5688 | 0.740 |
Why?
| Neuroendoscopy | 5 | 2024 | 19 | 0.710 |
Why?
| Postoperative Complications | 12 | 2024 | 2456 | 0.700 |
Why?
| Male | 65 | 2025 | 62757 | 0.700 |
Why?
| Transcriptome | 7 | 2023 | 879 | 0.670 |
Why?
| Diagnosis, Computer-Assisted | 1 | 2020 | 87 | 0.660 |
Why?
| Down Syndrome | 2 | 2020 | 469 | 0.650 |
Why?
| Reoperation | 6 | 2025 | 541 | 0.640 |
Why?
| Female | 66 | 2025 | 68016 | 0.630 |
Why?
| Neoplasm Recurrence, Local | 6 | 2024 | 955 | 0.590 |
Why?
| Retrospective Studies | 31 | 2024 | 14404 | 0.590 |
Why?
| Atlanto-Occipital Joint | 3 | 2024 | 4 | 0.590 |
Why?
| Treatment Outcome | 27 | 2024 | 10110 | 0.580 |
Why?
| Pituitary Diseases | 1 | 2017 | 21 | 0.550 |
Why?
| Central Nervous System Neoplasms | 2 | 2019 | 148 | 0.550 |
Why?
| Meningioma | 1 | 2018 | 80 | 0.550 |
Why?
| Third Ventricle | 4 | 2024 | 17 | 0.540 |
Why?
| Axis, Cervical Vertebra | 2 | 2022 | 7 | 0.540 |
Why?
| Meningeal Neoplasms | 1 | 2018 | 93 | 0.540 |
Why?
| Intracranial Hemorrhages | 2 | 2020 | 79 | 0.520 |
Why?
| Skull | 1 | 2017 | 128 | 0.520 |
Why?
| Supratentorial Neoplasms | 1 | 2015 | 19 | 0.500 |
Why?
| Ketorolac | 1 | 2015 | 18 | 0.490 |
Why?
| EGF Family of Proteins | 1 | 2015 | 17 | 0.490 |
Why?
| Pediatrics | 2 | 2020 | 1044 | 0.490 |
Why?
| Receptor, EphA2 | 1 | 2015 | 20 | 0.480 |
Why?
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2015 | 22 | 0.480 |
Why?
| ErbB Receptors | 2 | 2016 | 601 | 0.480 |
Why?
| Receptor, ErbB-3 | 1 | 2015 | 45 | 0.480 |
Why?
| Brain Injuries, Traumatic | 2 | 2019 | 337 | 0.480 |
Why?
| Temporal Lobe | 1 | 2015 | 85 | 0.480 |
Why?
| Choroid Plexus Neoplasms | 1 | 2014 | 9 | 0.470 |
Why?
| src-Family Kinases | 1 | 2015 | 95 | 0.460 |
Why?
| Perioperative Care | 1 | 2015 | 149 | 0.440 |
Why?
| Spinal Cord Injuries | 3 | 2024 | 191 | 0.430 |
Why?
| Data Collection | 2 | 2014 | 645 | 0.430 |
Why?
| Professional Practice | 1 | 2014 | 63 | 0.430 |
Why?
| Delayed Diagnosis | 2 | 2024 | 79 | 0.420 |
Why?
| Young Adult | 17 | 2021 | 12281 | 0.420 |
Why?
| Scoliosis | 3 | 2024 | 201 | 0.410 |
Why?
| Quality of Life | 5 | 2023 | 2672 | 0.410 |
Why?
| Moyamoya Disease | 2 | 2014 | 18 | 0.400 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 332 | 0.400 |
Why?
| Neurology | 1 | 2014 | 103 | 0.400 |
Why?
| Drug Delivery Systems | 1 | 2015 | 327 | 0.390 |
Why?
| Decision Support Systems, Clinical | 2 | 2025 | 205 | 0.380 |
Why?
| Artificial Intelligence | 2 | 2025 | 244 | 0.380 |
Why?
| Urethral Diseases | 1 | 2011 | 19 | 0.380 |
Why?
| Foreign-Body Migration | 1 | 2011 | 35 | 0.380 |
Why?
| Genomics | 1 | 2016 | 714 | 0.370 |
Why?
| Brain Injuries | 1 | 2016 | 463 | 0.370 |
Why?
| Intracranial Hypertension | 2 | 2010 | 37 | 0.360 |
Why?
| Cranial Sutures | 1 | 2010 | 9 | 0.350 |
Why?
| Craniotomy | 2 | 2008 | 68 | 0.350 |
Why?
| Cephalometry | 1 | 2010 | 30 | 0.350 |
Why?
| Odontoid Process | 1 | 2010 | 4 | 0.350 |
Why?
| Esthetics | 1 | 2010 | 50 | 0.340 |
Why?
| Craniosynostoses | 1 | 2010 | 33 | 0.340 |
Why?
| Biomarkers, Tumor | 3 | 2024 | 1175 | 0.340 |
Why?
| Societies, Medical | 1 | 2014 | 741 | 0.330 |
Why?
| Surgeons | 1 | 2014 | 259 | 0.330 |
Why?
| Internal Fixators | 1 | 2010 | 34 | 0.330 |
Why?
| Gene Expression Regulation, Neoplastic | 5 | 2024 | 1343 | 0.330 |
Why?
| Spinal Diseases | 1 | 2010 | 48 | 0.330 |
Why?
| Brain Stem | 1 | 2010 | 98 | 0.330 |
Why?
| Urinary Bladder | 1 | 2011 | 175 | 0.330 |
Why?
| MAP Kinase Signaling System | 2 | 2024 | 304 | 0.320 |
Why?
| Patient Discharge | 1 | 2016 | 850 | 0.320 |
Why?
| Cerebral Ventricles | 1 | 2009 | 49 | 0.320 |
Why?
| Anemia, Sickle Cell | 2 | 2014 | 253 | 0.310 |
Why?
| RNA, Messenger | 2 | 2017 | 2669 | 0.300 |
Why?
| Glomus Tumor | 1 | 2008 | 2 | 0.300 |
Why?
| Chromosomes, Human, Pair 1 | 2 | 2019 | 70 | 0.300 |
Why?
| Brain | 5 | 2023 | 2615 | 0.300 |
Why?
| Neuroimaging | 3 | 2020 | 278 | 0.300 |
Why?
| Orbital Neoplasms | 1 | 2008 | 20 | 0.300 |
Why?
| Follow-Up Studies | 9 | 2024 | 4853 | 0.300 |
Why?
| Insurance, Liability | 1 | 2008 | 6 | 0.290 |
Why?
| Cerebral Revascularization | 1 | 2008 | 19 | 0.290 |
Why?
| Surgical Wound Infection | 3 | 2022 | 281 | 0.290 |
Why?
| Proto-Oncogene Proteins B-raf | 3 | 2019 | 212 | 0.280 |
Why?
| Adult | 19 | 2021 | 35176 | 0.280 |
Why?
| Medically Underserved Area | 1 | 2008 | 83 | 0.280 |
Why?
| B7-H1 Antigen | 2 | 2020 | 189 | 0.270 |
Why?
| Programmed Cell Death 1 Receptor | 2 | 2020 | 226 | 0.270 |
Why?
| Granuloma | 2 | 2017 | 83 | 0.270 |
Why?
| Surgical Flaps | 1 | 2008 | 135 | 0.260 |
Why?
| Evidence-Based Medicine | 1 | 2010 | 709 | 0.260 |
Why?
| Clinical Decision-Making | 2 | 2019 | 302 | 0.260 |
Why?
| Prognosis | 7 | 2019 | 3766 | 0.250 |
Why?
| Autophagy | 2 | 2019 | 265 | 0.250 |
Why?
| Subdural Effusion | 1 | 2024 | 4 | 0.240 |
Why?
| Neocortex | 1 | 2025 | 33 | 0.230 |
Why?
| Pyramidal Cells | 1 | 2025 | 70 | 0.230 |
Why?
| Radiation Injuries | 2 | 2018 | 135 | 0.230 |
Why?
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2025 | 96 | 0.230 |
Why?
| Computational Biology | 3 | 2025 | 595 | 0.230 |
Why?
| Adrenoleukodystrophy | 1 | 2024 | 8 | 0.220 |
Why?
| Neuronavigation | 1 | 2024 | 7 | 0.220 |
Why?
| Intraoperative Neurophysiological Monitoring | 1 | 2024 | 21 | 0.220 |
Why?
| United States | 7 | 2020 | 13785 | 0.220 |
Why?
| Clonal Evolution | 1 | 2024 | 38 | 0.220 |
Why?
| Drainage | 1 | 2024 | 165 | 0.220 |
Why?
| Microarray Analysis | 4 | 2017 | 120 | 0.220 |
Why?
| Attitude of Health Personnel | 1 | 2011 | 1088 | 0.210 |
Why?
| Tumor Burden | 1 | 2024 | 283 | 0.210 |
Why?
| Cohort Studies | 8 | 2024 | 5378 | 0.210 |
Why?
| Meningomyelocele | 2 | 2025 | 58 | 0.210 |
Why?
| Astrocytoma | 1 | 2024 | 120 | 0.210 |
Why?
| Combined Modality Therapy | 3 | 2019 | 1199 | 0.210 |
Why?
| Brain Concussion | 2 | 2022 | 544 | 0.210 |
Why?
| Germinoma | 1 | 2022 | 13 | 0.200 |
Why?
| Pineal Gland | 1 | 2022 | 17 | 0.200 |
Why?
| Pinealoma | 1 | 2022 | 11 | 0.200 |
Why?
| Cysts | 1 | 2023 | 108 | 0.200 |
Why?
| Software | 2 | 2025 | 606 | 0.200 |
Why?
| Hypothalamic Neoplasms | 1 | 2022 | 9 | 0.200 |
Why?
| Developing Countries | 1 | 2024 | 285 | 0.190 |
Why?
| Hedgehog Proteins | 2 | 2022 | 187 | 0.190 |
Why?
| Hypothalamic Diseases | 1 | 2022 | 18 | 0.190 |
Why?
| beta Catenin | 2 | 2024 | 217 | 0.190 |
Why?
| Endoscopy | 2 | 2015 | 266 | 0.190 |
Why?
| Spine | 1 | 2023 | 156 | 0.190 |
Why?
| Drug Screening Assays, Antitumor | 2 | 2021 | 195 | 0.190 |
Why?
| Tumor Microenvironment | 3 | 2023 | 620 | 0.190 |
Why?
| Radiation | 1 | 2021 | 24 | 0.190 |
Why?
| Chromosome Aberrations | 2 | 2023 | 148 | 0.180 |
Why?
| Traction | 1 | 2021 | 19 | 0.180 |
Why?
| Neurosurgeons | 2 | 2019 | 17 | 0.180 |
Why?
| Epilepsy | 1 | 2025 | 322 | 0.180 |
Why?
| Kaplan-Meier Estimate | 4 | 2020 | 851 | 0.180 |
Why?
| Cranial Fossa, Posterior | 1 | 2020 | 17 | 0.180 |
Why?
| Disease Progression | 3 | 2024 | 2598 | 0.180 |
Why?
| Delphi Technique | 4 | 2025 | 221 | 0.170 |
Why?
| Equipment Failure | 1 | 2020 | 107 | 0.170 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2024 | 504 | 0.170 |
Why?
| Preoperative Period | 1 | 2020 | 113 | 0.170 |
Why?
| Databases, Factual | 2 | 2016 | 1264 | 0.170 |
Why?
| Cerebellar Neoplasms | 1 | 2022 | 156 | 0.170 |
Why?
| Neoplastic Cells, Circulating | 1 | 2020 | 70 | 0.170 |
Why?
| Middle Aged | 12 | 2020 | 30812 | 0.170 |
Why?
| Neoplasms, Neuroepithelial | 1 | 2019 | 17 | 0.160 |
Why?
| Sports | 1 | 2022 | 221 | 0.160 |
Why?
| Prophylactic Surgical Procedures | 1 | 2019 | 6 | 0.160 |
Why?
| Medulloblastoma | 1 | 2022 | 198 | 0.160 |
Why?
| Benchmarking | 1 | 2021 | 175 | 0.160 |
Why?
| Gene Expression Profiling | 4 | 2020 | 1681 | 0.160 |
Why?
| Adenomatous Polyposis Coli | 1 | 2019 | 33 | 0.160 |
Why?
| Spinal Cord Diseases | 1 | 2019 | 40 | 0.160 |
Why?
| Optic Nerve Neoplasms | 1 | 2019 | 12 | 0.160 |
Why?
| Optic Chiasm | 1 | 2019 | 19 | 0.160 |
Why?
| Intracranial Pressure | 1 | 2019 | 45 | 0.160 |
Why?
| Hematoma, Subdural | 1 | 2018 | 17 | 0.150 |
Why?
| Neoplasm Grading | 2 | 2021 | 283 | 0.150 |
Why?
| Healthcare Disparities | 1 | 2025 | 579 | 0.150 |
Why?
| Cerebellum | 1 | 2020 | 217 | 0.150 |
Why?
| Multivariate Analysis | 3 | 2020 | 1492 | 0.150 |
Why?
| Decompressive Craniectomy | 1 | 2018 | 6 | 0.150 |
Why?
| Craniospinal Irradiation | 1 | 2018 | 5 | 0.150 |
Why?
| Spinal Curvatures | 1 | 2018 | 3 | 0.150 |
Why?
| Specialties, Surgical | 1 | 2019 | 73 | 0.150 |
Why?
| Chemoradiotherapy | 1 | 2019 | 209 | 0.150 |
Why?
| Cell Line, Tumor | 4 | 2019 | 3168 | 0.150 |
Why?
| Risk Factors | 7 | 2022 | 9696 | 0.150 |
Why?
| Phenotype | 2 | 2024 | 3039 | 0.150 |
Why?
| Stromal Cells | 1 | 2018 | 105 | 0.150 |
Why?
| Skull Neoplasms | 1 | 2017 | 23 | 0.150 |
Why?
| Bone Transplantation | 1 | 2018 | 82 | 0.140 |
Why?
| Single-Cell Analysis | 1 | 2020 | 270 | 0.140 |
Why?
| Bone Resorption | 1 | 2018 | 80 | 0.140 |
Why?
| Oncogene Proteins, Fusion | 1 | 2019 | 198 | 0.140 |
Why?
| Cyst Fluid | 1 | 2017 | 26 | 0.140 |
Why?
| Hypophysitis | 1 | 2017 | 3 | 0.140 |
Why?
| Aged, 80 and over | 4 | 2018 | 7029 | 0.140 |
Why?
| Patient Admission | 1 | 2018 | 182 | 0.140 |
Why?
| Re-Irradiation | 1 | 2016 | 8 | 0.140 |
Why?
| Models, Theoretical | 1 | 2020 | 541 | 0.130 |
Why?
| Survival Analysis | 2 | 2023 | 1262 | 0.130 |
Why?
| Blood Transfusion | 1 | 2019 | 291 | 0.130 |
Why?
| Chloroquine | 1 | 2017 | 52 | 0.130 |
Why?
| Aged | 7 | 2019 | 21892 | 0.130 |
Why?
| Nurses | 1 | 2019 | 164 | 0.130 |
Why?
| Sarcoma, Ewing | 1 | 2017 | 87 | 0.130 |
Why?
| Glioblastoma | 2 | 2010 | 323 | 0.130 |
Why?
| Algorithms | 2 | 2022 | 1609 | 0.130 |
Why?
| Antineoplastic Agents | 2 | 2018 | 2041 | 0.130 |
Why?
| Observer Variation | 1 | 2017 | 310 | 0.130 |
Why?
| Organ Size | 1 | 2017 | 440 | 0.130 |
Why?
| Age Factors | 3 | 2020 | 3100 | 0.130 |
Why?
| Athletic Injuries | 1 | 2022 | 506 | 0.130 |
Why?
| Accidents, Traffic | 2 | 2014 | 186 | 0.130 |
Why?
| Consensus | 3 | 2025 | 607 | 0.130 |
Why?
| Cetirizine | 1 | 2015 | 2 | 0.120 |
Why?
| Nasal Sprays | 1 | 2015 | 3 | 0.120 |
Why?
| Ambrosia | 1 | 2015 | 7 | 0.120 |
Why?
| Amphiregulin | 1 | 2015 | 25 | 0.120 |
Why?
| Cataract | 1 | 2018 | 207 | 0.120 |
Why?
| Rhinitis, Allergic, Seasonal | 1 | 2015 | 31 | 0.120 |
Why?
| Fluticasone | 1 | 2015 | 90 | 0.120 |
Why?
| Length of Stay | 2 | 2019 | 1114 | 0.120 |
Why?
| Cytokines | 3 | 2018 | 1984 | 0.120 |
Why?
| Radiography | 4 | 2023 | 794 | 0.110 |
Why?
| Cerebral Veins | 1 | 2014 | 15 | 0.110 |
Why?
| Indoles | 1 | 2017 | 371 | 0.110 |
Why?
| Logistic Models | 3 | 2019 | 1975 | 0.110 |
Why?
| Chromosomes | 2 | 2024 | 101 | 0.110 |
Why?
| Disease-Free Survival | 1 | 2015 | 647 | 0.110 |
Why?
| Arachnoid Cysts | 1 | 2013 | 6 | 0.100 |
Why?
| Sulfonamides | 1 | 2017 | 494 | 0.100 |
Why?
| Central Nervous System Cysts | 1 | 2013 | 13 | 0.100 |
Why?
| Survival Rate | 2 | 2019 | 1870 | 0.100 |
Why?
| Neuropsychological Tests | 2 | 2023 | 1001 | 0.100 |
Why?
| Imaging, Three-Dimensional | 3 | 2017 | 529 | 0.100 |
Why?
| Carcinoma | 1 | 2014 | 215 | 0.100 |
Why?
| Seasons | 1 | 2015 | 498 | 0.100 |
Why?
| Neuroectodermal Tumors, Primitive | 1 | 2012 | 11 | 0.100 |
Why?
| Disease Models, Animal | 2 | 2019 | 3936 | 0.100 |
Why?
| Cerebral Angiography | 2 | 2014 | 109 | 0.100 |
Why?
| Emergency Service, Hospital | 1 | 2023 | 1896 | 0.100 |
Why?
| Up-Regulation | 1 | 2015 | 822 | 0.100 |
Why?
| Drug Resistance, Neoplasm | 1 | 2017 | 744 | 0.100 |
Why?
| Ischemic Attack, Transient | 2 | 2014 | 60 | 0.100 |
Why?
| Anti-Bacterial Agents | 1 | 2022 | 1689 | 0.100 |
Why?
| Proportional Hazards Models | 1 | 2015 | 1194 | 0.090 |
Why?
| Urethra | 1 | 2011 | 52 | 0.090 |
Why?
| Neoplasms, Multiple Primary | 1 | 2011 | 54 | 0.090 |
Why?
| Lymphangioma, Cystic | 1 | 2011 | 4 | 0.090 |
Why?
| Umbilicus | 1 | 2011 | 16 | 0.090 |
Why?
| Neurologic Examination | 1 | 2011 | 115 | 0.090 |
Why?
| Brachial Plexus | 1 | 2011 | 28 | 0.090 |
Why?
| Teratoma | 1 | 2011 | 103 | 0.090 |
Why?
| Hematoma, Epidural, Cranial | 1 | 2010 | 4 | 0.090 |
Why?
| Radiosurgery | 1 | 2014 | 318 | 0.090 |
Why?
| Magnetic Resonance Angiography | 2 | 2014 | 235 | 0.090 |
Why?
| Rhabdoid Tumor | 1 | 2011 | 97 | 0.090 |
Why?
| Gene Expression | 1 | 2015 | 1454 | 0.080 |
Why?
| Practice Patterns, Physicians' | 1 | 2018 | 1260 | 0.080 |
Why?
| Reproducibility of Results | 1 | 2017 | 3009 | 0.080 |
Why?
| Mutation | 4 | 2024 | 3682 | 0.080 |
Why?
| Skull Fracture, Depressed | 1 | 2008 | 1 | 0.080 |
Why?
| Head Injuries, Closed | 1 | 2008 | 50 | 0.080 |
Why?
| Computer Simulation | 3 | 2021 | 936 | 0.070 |
Why?
| Pia Mater | 1 | 2008 | 5 | 0.070 |
Why?
| Zygoma | 1 | 2008 | 7 | 0.070 |
Why?
| Electronic Health Records | 1 | 2016 | 973 | 0.070 |
Why?
| Functional Laterality | 1 | 2009 | 218 | 0.070 |
Why?
| Mice | 5 | 2024 | 16574 | 0.070 |
Why?
| Topography, Medical | 1 | 2008 | 11 | 0.070 |
Why?
| Diagnosis, Differential | 2 | 2012 | 1408 | 0.070 |
Why?
| Temporal Arteries | 1 | 2008 | 45 | 0.070 |
Why?
| Biopsy | 1 | 2011 | 1077 | 0.070 |
Why?
| Abnormalities, Multiple | 1 | 2009 | 178 | 0.070 |
Why?
| Foreign Bodies | 1 | 2008 | 101 | 0.070 |
Why?
| Models, Anatomic | 1 | 2008 | 88 | 0.070 |
Why?
| Prenatal Diagnosis | 1 | 2009 | 190 | 0.070 |
Why?
| Developmental Disabilities | 1 | 2010 | 258 | 0.070 |
Why?
| Paraganglioma | 1 | 2008 | 49 | 0.070 |
Why?
| Diagnostic Imaging | 1 | 2010 | 329 | 0.070 |
Why?
| Population Dynamics | 1 | 2008 | 136 | 0.070 |
Why?
| Recurrence | 1 | 2010 | 993 | 0.070 |
Why?
| Signal Transduction | 1 | 2020 | 4812 | 0.070 |
Why?
| Cognition Disorders | 1 | 2010 | 497 | 0.060 |
Why?
| Cerebrovascular Circulation | 1 | 2008 | 216 | 0.060 |
Why?
| Forecasting | 1 | 2008 | 355 | 0.060 |
Why?
| Health Services Needs and Demand | 1 | 2008 | 262 | 0.060 |
Why?
| Gestational Age | 1 | 2009 | 868 | 0.060 |
Why?
| Head and Neck Neoplasms | 1 | 2011 | 532 | 0.060 |
Why?
| Malformations of Cortical Development | 1 | 2025 | 14 | 0.060 |
Why?
| Registries | 2 | 2025 | 1873 | 0.060 |
Why?
| Cranial Fontanelles | 1 | 2024 | 4 | 0.060 |
Why?
| Cell Survival | 2 | 2019 | 1073 | 0.060 |
Why?
| Seizures | 1 | 2008 | 400 | 0.060 |
Why?
| Glasgow Coma Scale | 2 | 2018 | 167 | 0.060 |
Why?
| Stroke | 2 | 2014 | 1063 | 0.060 |
Why?
| X-ray Repair Cross Complementing Protein 1 | 1 | 2023 | 14 | 0.060 |
Why?
| Radiotherapy, Adjuvant | 1 | 2024 | 209 | 0.050 |
Why?
| Isocitrate Dehydrogenase | 1 | 2024 | 51 | 0.050 |
Why?
| Drug Resistant Epilepsy | 1 | 2025 | 83 | 0.050 |
Why?
| Intelligence Tests | 1 | 2023 | 58 | 0.050 |
Why?
| Heart Atria | 1 | 2024 | 127 | 0.050 |
Why?
| Cranial Irradiation | 1 | 2023 | 68 | 0.050 |
Why?
| Prospective Studies | 3 | 2024 | 7035 | 0.050 |
Why?
| Sex Factors | 1 | 2009 | 1942 | 0.050 |
Why?
| Fluorouracil | 1 | 2024 | 197 | 0.050 |
Why?
| Animals | 5 | 2024 | 34487 | 0.050 |
Why?
| Patients' Rooms | 1 | 2022 | 13 | 0.050 |
Why?
| Abdomen | 1 | 2023 | 116 | 0.050 |
Why?
| Narcotics | 1 | 2022 | 45 | 0.050 |
Why?
| Mass Screening | 1 | 2010 | 1145 | 0.050 |
Why?
| Action Potentials | 1 | 2025 | 468 | 0.050 |
Why?
| Catheters | 1 | 2022 | 66 | 0.050 |
Why?
| Multicenter Studies as Topic | 1 | 2023 | 285 | 0.050 |
Why?
| Gene Ontology | 1 | 2021 | 48 | 0.050 |
Why?
| Vancomycin | 1 | 2022 | 78 | 0.050 |
Why?
| Slit Ventricle Syndrome | 1 | 2020 | 1 | 0.050 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2023 | 201 | 0.050 |
Why?
| Postoperative Care | 1 | 2022 | 235 | 0.040 |
Why?
| Transplants | 1 | 2021 | 35 | 0.040 |
Why?
| Cell Proliferation | 2 | 2019 | 2337 | 0.040 |
Why?
| Models, Biological | 1 | 2008 | 1689 | 0.040 |
Why?
| Transplantation, Heterologous | 1 | 2021 | 187 | 0.040 |
Why?
| DNA Copy Number Variations | 1 | 2021 | 169 | 0.040 |
Why?
| Survivors | 1 | 2023 | 462 | 0.040 |
Why?
| Transplantation, Autologous | 1 | 2021 | 211 | 0.040 |
Why?
| Recovery of Function | 1 | 2024 | 630 | 0.040 |
Why?
| Genes, APC | 1 | 2019 | 13 | 0.040 |
Why?
| Aminopyridines | 1 | 2019 | 95 | 0.040 |
Why?
| Mice, SCID | 1 | 2019 | 350 | 0.040 |
Why?
| Asymptomatic Diseases | 1 | 2019 | 83 | 0.040 |
Why?
| Blood Loss, Surgical | 1 | 2019 | 90 | 0.040 |
Why?
| Critical Care Nursing | 1 | 2019 | 36 | 0.040 |
Why?
| Benzamides | 1 | 2019 | 195 | 0.040 |
Why?
| Athletes | 1 | 2022 | 407 | 0.040 |
Why?
| Surgical Wound | 1 | 2018 | 20 | 0.040 |
Why?
| Germ-Line Mutation | 1 | 2019 | 138 | 0.040 |
Why?
| Point Mutation | 1 | 2019 | 221 | 0.040 |
Why?
| Electronic Mail | 1 | 2018 | 60 | 0.040 |
Why?
| Immunohistochemistry | 2 | 2013 | 1663 | 0.040 |
Why?
| Longitudinal Studies | 2 | 2018 | 2706 | 0.040 |
Why?
| Odontogenesis | 1 | 2018 | 11 | 0.040 |
Why?
| Weight Gain | 1 | 2022 | 503 | 0.040 |
Why?
| Laser Capture Microdissection | 1 | 2018 | 21 | 0.040 |
Why?
| Standard of Care | 1 | 2018 | 72 | 0.040 |
Why?
| Tissue Culture Techniques | 1 | 2018 | 68 | 0.040 |
Why?
| Mice, Inbred NOD | 1 | 2019 | 586 | 0.040 |
Why?
| Tumor Cells, Cultured | 1 | 2019 | 930 | 0.040 |
Why?
| Drug Approval | 1 | 2018 | 86 | 0.040 |
Why?
| Receptors, HIV | 1 | 2017 | 26 | 0.040 |
Why?
| Mucin-1 | 1 | 2017 | 20 | 0.040 |
Why?
| Receptors, Interleukin-6 | 1 | 2017 | 37 | 0.040 |
Why?
| Cytogenetic Analysis | 1 | 2017 | 33 | 0.040 |
Why?
| Fluorescent Antibody Technique | 1 | 2018 | 370 | 0.040 |
Why?
| Canada | 1 | 2018 | 344 | 0.040 |
Why?
| DNA-Binding Proteins | 2 | 2017 | 1421 | 0.030 |
Why?
| Pituitary Gland | 1 | 2018 | 148 | 0.030 |
Why?
| Overweight | 1 | 2022 | 522 | 0.030 |
Why?
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2017 | 54 | 0.030 |
Why?
| Monitoring, Physiologic | 1 | 2019 | 264 | 0.030 |
Why?
| Prevalence | 2 | 2016 | 2541 | 0.030 |
Why?
| Heart-Assist Devices | 1 | 2003 | 536 | 0.030 |
Why?
| Treatment Failure | 1 | 2018 | 338 | 0.030 |
Why?
| Heart Transplantation | 1 | 2003 | 711 | 0.030 |
Why?
| Ki-67 Antigen | 1 | 2017 | 107 | 0.030 |
Why?
| Brain Diseases | 1 | 2018 | 136 | 0.030 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 2017 | 92 | 0.030 |
Why?
| Neuroglia | 1 | 2018 | 165 | 0.030 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2019 | 809 | 0.030 |
Why?
| Blotting, Western | 1 | 2019 | 1169 | 0.030 |
Why?
| Intensive Care Units, Pediatric | 1 | 2018 | 201 | 0.030 |
Why?
| Transcription Factors | 2 | 2017 | 1628 | 0.030 |
Why?
| Wounds, Nonpenetrating | 1 | 2019 | 271 | 0.030 |
Why?
| Pregnancy | 1 | 2009 | 6355 | 0.030 |
Why?
| Health Surveys | 1 | 2018 | 491 | 0.030 |
Why?
| DNA Methylation | 1 | 2021 | 604 | 0.030 |
Why?
| Interviews as Topic | 1 | 2019 | 714 | 0.030 |
Why?
| Microscopy, Confocal | 1 | 2017 | 307 | 0.030 |
Why?
| Pandemics | 1 | 2024 | 1473 | 0.030 |
Why?
| Pyrimidines | 1 | 2019 | 446 | 0.030 |
Why?
| Drug Synergism | 1 | 2017 | 356 | 0.030 |
Why?
| Flow Cytometry | 1 | 2019 | 1140 | 0.030 |
Why?
| Sequence Analysis, RNA | 1 | 2018 | 427 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2020 | 1934 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2020 | 1813 | 0.030 |
Why?
| Lumbar Vertebrae | 1 | 2016 | 230 | 0.030 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2016 | 253 | 0.030 |
Why?
| Quality Improvement | 1 | 2022 | 1093 | 0.030 |
Why?
| Illinois | 1 | 2013 | 39 | 0.030 |
Why?
| Chicago | 1 | 2013 | 57 | 0.030 |
Why?
| Body Mass Index | 1 | 2022 | 2260 | 0.030 |
Why?
| Nuclear Proteins | 1 | 2017 | 657 | 0.020 |
Why?
| Qualitative Research | 1 | 2019 | 1224 | 0.020 |
Why?
| Necrosis | 1 | 2013 | 228 | 0.020 |
Why?
| History, 19th Century | 1 | 2011 | 57 | 0.020 |
Why?
| Case-Control Studies | 1 | 2019 | 3324 | 0.020 |
Why?
| SMARCB1 Protein | 1 | 2011 | 29 | 0.020 |
Why?
| Germany | 1 | 2011 | 97 | 0.020 |
Why?
| Incidence | 1 | 2018 | 2614 | 0.020 |
Why?
| Clinical Competence | 1 | 2018 | 1007 | 0.020 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2011 | 115 | 0.020 |
Why?
| Arthritis, Juvenile | 1 | 2011 | 53 | 0.020 |
Why?
| Apoptosis | 1 | 2019 | 2425 | 0.020 |
Why?
| Practice Guidelines as Topic | 1 | 2018 | 1482 | 0.020 |
Why?
| Abducens Nerve Diseases | 1 | 2010 | 12 | 0.020 |
Why?
| History, 20th Century | 1 | 2011 | 285 | 0.020 |
Why?
| Brain Ischemia | 1 | 2014 | 305 | 0.020 |
Why?
| Joint Dislocations | 1 | 2010 | 50 | 0.020 |
Why?
| Range of Motion, Articular | 1 | 2011 | 360 | 0.020 |
Why?
| Clothing | 1 | 2008 | 19 | 0.020 |
Why?
| Obesity | 1 | 2022 | 2859 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2009 | 419 | 0.020 |
Why?
| Inflammation | 1 | 2018 | 2646 | 0.020 |
Why?
| Bacterial Infections | 1 | 2009 | 232 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2018 | 5034 | 0.020 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2013 | 2059 | 0.020 |
Why?
| New York | 1 | 2003 | 124 | 0.010 |
Why?
| Shock, Cardiogenic | 1 | 2003 | 59 | 0.010 |
Why?
| Emergency Treatment | 1 | 2003 | 113 | 0.010 |
Why?
| Risk Assessment | 1 | 2010 | 3223 | 0.010 |
Why?
| Stroke Volume | 1 | 2003 | 588 | 0.010 |
Why?
| Hospital Mortality | 1 | 2003 | 844 | 0.010 |
Why?
| Intensive Care Units | 1 | 2003 | 734 | 0.010 |
Why?
| Heart Ventricles | 1 | 2003 | 765 | 0.010 |
Why?
| Time Factors | 1 | 2003 | 6479 | 0.010 |
Why?
| Heart Failure | 1 | 2003 | 2141 | 0.010 |
Why?
|
|
Hankinson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|